Lumida
/ALT
⌘K
Altimmune Inc

Altimmune Inc

ALT
$2.87USD+0.70%+0.02 today

MARKET CAP

558.1M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $3

52W RANGE

$3
$6

AI Summary

Stalk
TrimMedium

In the Stage 4 decline, ALT remains in a lower-high/lower-low sequence below all major EMAs. Price action is sideways and indecisive around the 9/21 EMA band with RSI neutral. Medium-term structure is bearish while the long-term trend stays up. Execution calls for trimming into rallies up to the EMA resistance zone.

  • Secured $535M cash runway to support Phase 3 MASH trials through 2029
  • 59.1% of subjects achieved MASH resolution at 24 weeks in Pembedutide trial
  • Earnings yield remains negative and profitability metrics are weak
Full analysis →
Insider Trades40 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Apr 1, 2026BuyALTGregory L WeaverChief Financial Officer10,000$3.15$558.1M-55.43%+12.11%$31.5K+35.62%Trim
Apr 1, 2026BuyALTJerome Benedict DursoPresident and CEO15,000$3.14$558.1M-55.43%+12.11%$47.1K+46.15%Trim
Mar 6, 2026BuyALTGregory L WeaverChief Financial Officer5,000$3.54$558.1M-55.43%+12.11%$17.7K+21.67%Trim
Mar 6, 2026BuyALTJerome Benedict DursoPresident and CEO20,000$3.54$558.1M-55.43%+12.11%$70.8K+160.00%Trim
Jan 31, 2026BuyALTRaymond M JordtChief Business Officer4,571$3.07$558.1M-55.43%+12.11%$14.0K+6.97%Trim
Jan 30, 2026BuyALTM Scot RobertsChief Scientific Officer10,755$4.28$558.1M-55.43%+12.11%$46.0K+0.11%Trim
Jan 27, 2026SellALTRaymond M JordtChief Business Officer4,229$6.18$558.1M-55.43%+12.11%$26.1K-3.60%Trim
Jan 27, 2026SellALTM Scot RobertsChief Scientific Officer4,748$6.18$558.1M-55.43%+12.11%$29.3K-3.21%Trim
Jan 25, 2026SellALTRaymond M JordtChief Business Officer3,855$5.50$558.1M-55.43%+12.11%$21.2K-4.43%Trim
Jan 25, 2026SellALTM Scot RobertsChief Scientific Officer4,373$5.50$558.1M-55.43%+12.11%$24.1K-3.71%Trim
Jan 1, 2026SellALTRaymond M JordtChief Business Officer2,475$3.61$558.1M-55.43%+12.11%$8.9K-4.50%Trim
Nov 11, 2025SellALTGregory L WeaverChief Financial Officer5,672$4.28$558.1M-55.43%+12.11%$24.3K-6.67%Trim
Jul 31, 2025BuyALTM Scot RobertsChief Scientific Officer846$3.14$558.1M-55.43%+12.11%$2.7K+1.16%Trim
Jul 31, 2025BuyALTRaymond M JordtChief Business Officer1,368$3.14$558.1M-55.43%+12.11%$4.3K+3.92%Trim
Jul 31, 2025BuyALTMatthew Scott HarrisChief Medical Officer2,018$3.14$558.1M-55.43%+12.11%$6.3K+14.34%Trim
Mar 13, 2025BuyALTGregory L WeaverChief Financial Officer10,000$5.20$558.1M-55.43%+12.11%$52.0KTrim
Mar 7, 2025SellALTMatthew Scott HarrisChief Medical Officer67,787$5.57$558.1M-55.43%+12.11%$377.6K-82.81%Trim
Jan 31, 2025BuyALTRaymond M JordtChief Business Officer2,614$5.18$558.1M-55.43%+12.11%$13.5K+8.10%Trim
Jan 30, 2025SellALTM Scot RobertsChief Scientific Officer10,010$6.27$558.1M-55.43%+12.11%$62.8K-1.24%Trim
Jan 30, 2025SellALTMatthew Scott HarrisChief Medical Officer9,895$6.47$558.1M-55.43%+12.11%$64.1K-1.82%Trim
Jan 30, 2025SellALTVipin K GargPresident and CEO31,319$6.58$558.1M-55.43%+12.11%$206.2K-1.58%Trim
Jan 25, 2025SellALTRaymond M JordtChief Business Officer3,862$6.98$558.1M-55.43%+12.11%$27.0K-1.18%Trim
Jan 25, 2025SellALTM Scot RobertsChief Scientific Officer4,264$6.98$558.1M-55.43%+12.11%$29.8K-1.22%Trim
Jan 25, 2025SellALTMatthew Scott HarrisChief Medical Officer4,994$6.98$558.1M-55.43%+12.11%$34.9K-1.39%Trim
Jan 25, 2025SellALTVipin K GargPresident and CEO18,157$6.98$558.1M-55.43%+12.11%$126.7K-1.65%Trim
Jan 1, 2025SellALTRaymond M JordtChief Business Officer2,485$7.21$558.1M-55.43%+12.11%$17.9K-5.81%Trim
Jul 31, 2024BuyALTM Scot RobertsChief Scientific Officer650$5.41$558.1M-55.43%+12.11%$3.5K+1.52%Trim
Jul 31, 2024BuyALTRaymond M JordtChief Business Officer917$5.41$558.1M-55.43%+12.11%$5.0K+6.67%Trim
Jul 31, 2024BuyALTAndrew ShutterlyActing Chief Financial Officer1,259$5.41$558.1M-55.43%+12.11%$6.8K+12.45%Trim
Jul 31, 2024BuyALTMatthew Scott HarrisChief Medical Officer1,486$5.41$558.1M-55.43%+12.11%$8.0K+2.77%Trim
Feb 1, 2024SellALTM Scot RobertsChief Scientific Officer4,131$9.56$558.1M-55.43%+12.11%$39.5K-3.91%Trim
Feb 1, 2024SellALTMatthew Scott HarrisChief Medical Officer4,133$9.56$558.1M-55.43%+12.11%$39.5K-3.24%Trim
Feb 1, 2024SellALTVipin K GargPresident and CEO15,689$9.58$558.1M-55.43%+12.11%$150.3K-2.44%Trim
Jan 31, 2024BuyALTRaymond M JordtChief Business Officer5,030$2.69$558.1M-55.43%+12.11%$13.5K+57.73%Trim
Jan 30, 2024BuyALTRichard I EisenstadtChief Financial Officer6,796$4.97$558.1M-55.43%+12.11%$33.7K+2.21%Trim
Jan 30, 2024BuyALTMatthew Scott HarrisChief Medical Officer5,966$5.92$558.1M-55.43%+12.11%$35.3K+0.49%Trim
Jan 30, 2024BuyALTM Scot RobertsChief Scientific Officer8,569$4.94$558.1M-55.43%+12.11%$42.3K+3.73%Trim
Jan 30, 2024SellALTVipin K GargPresident and CEO19,586$6.94$558.1M-55.43%+12.11%$135.9K-0.61%Trim
Jan 1, 2024SellALTRaymond M JordtChief Business Officer2,503$11.25$558.1M-55.43%+12.11%$28.2K-6.36%Trim
Dec 29, 2023SellALTRichard I EisenstadtChief Financial Officer3,044$11.25$558.1M-55.43%+12.11%$34.2K-4.96%Trim